{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:15:48Z","timestamp":1787242548330,"version":"build-2736575974"},"reference-count":40,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["gimjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Genetics in Medicine"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1038\/s41436-021-01274-y","type":"journal-article","created":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T12:21:07Z","timestamp":1626438067000},"page":"2378-2385","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Caffey disease is associated with distinct arginine to cysteine substitutions in the pro\u03b11(I) chain of type I procollagen"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5010-0304","authenticated-orcid":false,"given":"Tibbe","family":"Dhooge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delfien","family":"Syx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trinh","family":"Hermanns-L\u00ea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Hausser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geert","family":"Mortier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Zonana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofie","family":"Symoens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter H.","family":"Byers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fransiska","family":"Malfait","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/s41436-021-01274-y_bb0010","article-title":"On some late skeletal changes in chronic infantile cortical hyperostosis","volume":"59","author":"Caffey","year":"1952"},{"key":"10.1038\/s41436-021-01274-y_bb0015","article-title":"Infantile cortical hyperostosis (Caffey disease): a review","volume":"66","author":"Kamoun-Goldrat","year":"2008"},{"key":"10.1038\/s41436-021-01274-y_bb0020","article-title":"A novel COL1A1 mutation in infantile cortical hyperostosis (Caffey disease) expands the spectrum of collagen-related disorders","volume":"115","author":"Gensure","year":"2005"},{"key":"10.1038\/s41436-021-01274-y_bb0025","article-title":"Prenatal cortical hyperostosis with COL1A1 gene mutation","volume":"146A","author":"Kamoun-Goldrat","year":"2008"},{"key":"10.1038\/s41436-021-01274-y_bb0030","article-title":"Recurrence of infantile cortical hyperostosis: a case report and review of the literature","volume":"33","author":"Navarre","year":"2013"},{"key":"10.1038\/s41436-021-01274-y_bb0035","article-title":"Two Japanese familial cases of Caffey disease with and without the common COL1A1 mutation and normal bone density, and review of the literature","volume":"173","author":"Kitaoka","year":"2014"},{"key":"10.1038\/s41436-021-01274-y_bb0040","article-title":"Fetuin-A deficiency is associated with infantile cortical hyperostosis (Caffey disease)","volume":"86","author":"Merdler-Rabinowicz","year":"2019"},{"key":"10.1038\/s41436-021-01274-y_bb0045","article-title":"Antenatal onset of cortical hyperostosis (Caffey disease): case report and review","volume":"120A","author":"Schweiger","year":"2003"},{"key":"10.1038\/s41436-021-01274-y_bb0050","article-title":"Bi-allelic AEBP1 mutations in two patients with Ehlers\u2013Danlos syndrome","volume":"28","author":"Syx","year":"2019"},{"key":"10.1038\/s41436-021-01274-y_bb0055","article-title":"Novel defects in collagen XII and VI expand the mixed myopathy\/Ehlers\u2013Danlos syndrome spectrum and lead to variant-specific alterations in the extracellular matrix","volume":"22","author":"Delbaere","year":"2020"},{"key":"10.1038\/s41436-021-01274-y_bb0060","article-title":"Biallelic B3GALT6 mutations cause spondylodysplastic Ehlers\u2013Danlos syndrome","volume":"27","author":"Van Damme","year":"2018"},{"key":"10.1038\/s41436-021-01274-y_bb0065","article-title":"Three arginine to cysteine substitutions in the pro-alpha (I)-collagen chain cause Ehlers\u2013Danlos syndrome with a propensity to arterial rupture in early adulthood","volume":"28","author":"Malfait","year":"2007"},{"key":"10.1038\/s41436-021-01274-y_bb0070","article-title":"Sixteen novel mutations in PNPLA1 in patients with autosomal recessive congenital ichthyosis reveal the importance of an extended patatin domain in PNPLA1 that is essential for proper human skin barrier function","volume":"177","author":"Zimmer","year":"2017"},{"key":"10.1038\/s41436-021-01274-y_bb0075","article-title":"Candidate cell and matrix interaction domains on the collagen fibril, the predominant protein of vertebrates","volume":"283","author":"Sweeney","year":"2008"},{"key":"10.1038\/s41436-021-01274-y_bb0080","article-title":"Collagens serve as an extracellular store of bioactive interleukin 2","volume":"275","author":"Somasundaram","year":"2000"},{"key":"10.1038\/s41436-021-01274-y_bb0085","article-title":"Infantile cortical hyperostosis and COL1A1 mutation in four generations","volume":"170","author":"Cerruti-Mainardi","year":"2011"},{"key":"10.1038\/s41436-021-01274-y_bb0090","article-title":"The c.3040C>T mutation in COL1A1 is recurrent in Korean patients with infantile cortical hyperostosis (Caffey disease)","volume":"53","author":"Cho","year":"2008"},{"key":"10.1038\/s41436-021-01274-y_bb0095","article-title":"Osteogenesis imperfecta","volume":"387","author":"Forlino","year":"2016"},{"key":"10.1038\/s41436-021-01274-y_bb0100","article-title":"Classical Ehlers\u2013Danlos syndrome caused by a mutation in type I collagen","volume":"66","author":"Nuytinck","year":"2000"},{"key":"10.1038\/s41436-021-01274-y_bb0105","article-title":"Substitutions for arginine at position 780 in triple helical domain of the alpha1(I) chain alter folding of the type I procollagen molecule and cause osteogenesis imperfecta","volume":"13","author":"Makareeva","year":"2018"},{"key":"10.1038\/s41436-021-01274-y_bb0110","article-title":"Y-position cysteine substitution in type I collagen (alpha1(I) R888C\/p.R1066C) is associated with osteogenesis imperfecta\/Ehlers\u2013Danlos syndrome phenotype","volume":"28","author":"Cabral","year":"2007"},{"key":"10.1038\/s41436-021-01274-y_bb0115","article-title":"A novel arginine-to-cysteine substitution in the triple helical region of the alpha1(I) collagen chain in a family with an osteogenesis imperfecta\/Ehlers\u2013Danlos phenotype","volume":"73","author":"Lund","year":"2008"},{"key":"10.1038\/s41436-021-01274-y_bb0120","article-title":"Delineation of Ehlers\u2013Danlos syndrome phenotype due to the c.934C>T, p.(Arg312Cys) mutation in COL1A1: Report on a three-generation family without cardiovascular events, and literature review","volume":"173","author":"Colombi","year":"2017"},{"key":"10.1038\/s41436-021-01274-y_bb0125","article-title":"A family with Classical Ehlers\u2013Danlos syndrome (cEDS), mild bone fragility and without vascular complications, caused by the p.Arg312Cys mutation in COL1A1","volume":"63","author":"Duong","year":"2020"},{"key":"10.1038\/s41436-021-01274-y_bb0130","article-title":"Caffey disease: new perspectives on old questions","volume":"60","author":"Nistala","year":"2014"},{"key":"10.1038\/s41436-021-01274-y_bb0135","article-title":"Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans","volume":"28","author":"Marini","year":"2007"},{"key":"10.1038\/s41436-021-01274-y_bb0140","article-title":"Procollagen trafficking, processing and fibrillogenesis","volume":"118","author":"Canty","year":"2005"},{"key":"10.1038\/s41436-021-01274-y_bb0145","article-title":"The essential role of fetuin in the serum-induced calcification of collagen","volume":"82","author":"Toroian","year":"2008"},{"key":"10.1038\/s41436-021-01274-y_bb0150","article-title":"The phenotypic spectrum in patients with arginine to cysteine mutations in the COL2A1 gene","volume":"43","author":"Hoornaert","year":"2006"},{"key":"10.1038\/s41436-021-01274-y_bb0155","article-title":"Cortical hyperostosis following long-term administration of prostaglandin E1 in infants with cyanotic congenital heart disease","volume":"97","author":"Ueda","year":"1980"},{"key":"10.1038\/s41436-021-01274-y_bb0160","article-title":"Domain-specific mutations in TGFB1 result in Camurati\u2013Engelmann disease","volume":"26","author":"Kinoshita","year":"2000"},{"key":"10.1038\/s41436-021-01274-y_bb0165","article-title":"Thromboxane synthase mutations in an increased bone density disorder (Ghosal syndrome)","volume":"40","author":"Genevi\u00e8ve","year":"2008"},{"key":"10.1038\/s41436-021-01274-y_bb0170","article-title":"Prostaglandin synthetase inhibitor in Caffey disease","volume":"101","author":"Heyman","year":"1982"},{"key":"10.1038\/s41436-021-01274-y_bb0175","article-title":"Fetuin-A regulation of calcified matrix metabolism","volume":"108","author":"Jahnen-Dechent","year":"2011"},{"key":"10.1038\/s41436-021-01274-y_bb0180","article-title":"Fetuin\/alpha2-HS glycoprotein is a transforming growth factor-beta type II receptor mimic and cytokine antagonist","volume":"271","author":"Demetriou","year":"1996"},{"key":"10.1038\/s41436-021-01274-y_bb0185","article-title":"alpha 2-HS glycoprotein\/fetuin, a transforming growth factor-beta\/bone morphogenetic protein antagonist, regulates postnatal bone growth and remodeling","volume":"277","author":"Szweras","year":"2002"},{"key":"10.1038\/s41436-021-01274-y_bb0190","article-title":"Differentiation and cell surface expression of transforming growth factor-beta receptors are regulated by interaction with matrix collagen in murine osteoblastic cells","volume":"271","author":"Takeuchi","year":"1996"},{"key":"10.1038\/s41436-021-01274-y_bb0195","article-title":"Multiple signaling pathways converge on the Cbfa1\/Runx2 transcription factor to regulate osteoblast differentiation","volume":"44","author":"Franceschi","year":"2003"},{"key":"10.1038\/s41436-021-01274-y_bb0200","article-title":"Fibronectin protects from excessive liver fibrosis by modulating the availability of and responsiveness of stellate cells to active TGF-beta","volume":"6","author":"Kawelke","year":"2011"},{"key":"10.1038\/s41436-021-01274-y_bb0205","article-title":"Immune responses in neonates","volume":"10","author":"Basha","year":"2014"}],"container-title":["Genetics in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41436-021-01274-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41436-021-01274-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098360021054459?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098360021054459?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41436-021-01274-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T01:54:51Z","timestamp":1761098091000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098360021054459"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":40,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S1098360021054459"],"URL":"https:\/\/doi.org\/10.1038\/s41436-021-01274-y","relation":{},"ISSN":["1098-3600"],"issn-type":[{"value":"1098-3600","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Caffey disease is associated with distinct arginine to cysteine substitutions in the pro\u03b11(I) chain of type I procollagen","name":"articletitle","label":"Article Title"},{"value":"Genetics in Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/s41436-021-01274-y","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021, The Author(s), under exclusive licence to the American College of Medical Genetics and Genomics","name":"copyright","label":"Copyright"}]}}